Suppr超能文献

研究伊贝沙坦通过调节肠道菌群参与改善高原性肺动脉高压大鼠的氧化应激。

Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora.

机构信息

College of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, China.

出版信息

Eur Rev Med Pharmacol Sci. 2021 Jul;25(13):4540-4553. doi: 10.26355/eurrev_202107_26247.

Abstract

OBJECTIVE

High-altitude pulmonary hypertension (HAPH) is one of the diseases with higher occurrence among people living in plateau areas. The possible mechanism of angiotensin II receptor 1 inhibitor irbesartan in improving HAPH was explored from the perspective of intestinal bacterial flora in this study.

MATERIALS AND METHODS

A HAPH rat model was established under simulated high-altitude hypobaric hypoxia. The levels of oxidative stress and vasoactive substances were detected after irbesartan intervention, and intestinal flora genomics analysis was performed.

RESULTS

High-altitude hypobaric hypoxia-induced the increase in pulmonary artery pressure and left ventricular systolic dysfunction in HAPH model rats, but its effects were alleviated by irbesartan. Changes in the levels of oxidative damage in intestinal tissues, such as the increase in superoxide dismutase and glutathione peroxidase in intestinal tissues and the decrease in malondialdehyde content, were also reversed by irbesartan. The serum levels of angiotensin II, endothelin 1, interleukin-6, and C-reactive protein increased substantially whereas the level of nitric oxide decreased in HAPH model rats. The levels of these vasoconstriction and inflammatory indicators were also reversed after irbesartan intervention. The distribution of intestinal florae in rats was changed by the simulated high-altitude hypoxia environment as manifested by the increased Firmicutes-to-Bacteroidetes ratio (F/B), the increased abundance of Lactobacillaceae and Lachnospiraceae, and the decreased abundance of Prevotellaceae and Desulfovibrionaceae at the family level. However, the changes in F/B ratio and the abundance of these florae were reversed by irbesartan.

CONCLUSIONS

Irbesartan can alleviate pulmonary artery pressure and left ventricular relaxation in HAPH model rats, reduce the oxidative damage caused by high-altitude hypoxia, and lower the release of vasoconstrictor factors and inflammatory mediators. These effects might be caused by the increased abundance of Lactobacillaceae and Lachnospiraceae and the decreased abundance of Prevotellaceae and Desulfovibrionaceae in the intestines.

摘要

目的

高原地区人群中高发疾病之一是高山性肺动脉高压(HAPH)。本研究从肠道菌群角度探讨血管紧张素Ⅱ受体 1 抑制剂厄贝沙坦改善 HAPH 的可能机制。

材料与方法

在模拟高原低压缺氧条件下建立 HAPH 大鼠模型,厄贝沙坦干预后检测氧化应激和血管活性物质水平,并进行肠道菌群基因组学分析。

结果

高原低压缺氧导致 HAPH 模型大鼠肺动脉压升高和左心室收缩功能障碍,厄贝沙坦可减轻其作用。厄贝沙坦还可逆转肠道组织氧化损伤水平的变化,如肠道组织中超氧化物歧化酶和谷胱甘肽过氧化物酶升高,丙二醛含量降低。HAPH 模型大鼠血清中血管紧张素Ⅱ、内皮素 1、白细胞介素 6 和 C 反应蛋白水平显著升高,而一氧化氮水平降低。厄贝沙坦干预后,这些血管收缩和炎症指标的水平也得到了逆转。模拟高原缺氧环境改变了大鼠肠道菌群的分布,表现为厚壁菌门与拟杆菌门比值(F/B)增加、乳杆菌科和lachnospiraceae 丰度增加、普雷沃氏菌科和脱硫弧菌科丰度降低。然而,厄贝沙坦可逆转 F/B 比值和这些菌群的变化。

结论

厄贝沙坦可减轻 HAPH 模型大鼠肺动脉压和左心室舒张功能障碍,减轻高原缺氧引起的氧化损伤,降低血管收缩因子和炎症介质的释放。这些作用可能是由于肠道中乳杆菌科和lachnospiraceae 的丰度增加和普雷沃氏菌科和脱硫弧菌科的丰度降低所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验